0001493152-18-003516.txt : 20180316 0001493152-18-003516.hdr.sgml : 20180316 20180316171127 ACCESSION NUMBER: 0001493152-18-003516 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20180316 DATE AS OF CHANGE: 20180316 EFFECTIVENESS DATE: 20180316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROLUNG INC CENTRAL INDEX KEY: 0001541884 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 201922768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307971 FILM NUMBER: 18696578 BUSINESS ADDRESS: STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150 CITY: SALT LAKE CITY STATE: UT ZIP: 84102 BUSINESS PHONE: 801-204-9623 MAIL ADDRESS: STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150 CITY: SALT LAKE CITY STATE: UT ZIP: 84102 FORMER COMPANY: FORMER CONFORMED NAME: FRESH MEDICAL LABORATORIES, INC. DATE OF NAME CHANGE: 20120209 D 1 primary_doc.xml X0708 D LIVE 0001541884 PROLUNG INC 757 EAST SOUTH TEMPLE SUITE 150 SALT LAKE CITY UT UTAH 84102 801-204-9623 DELAWARE Fresh Medical Laboratories, Inc. FRESH MEDICAL LABORATORIES, INC. Corporation true Steven C Eror 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Executive Officer Director Michael A Garff 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Executive Officer Mark V Anderson 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Executive Officer Robin L Smith 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director Robert W Raybould 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director Todd M Morgan 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director John C Ruckdeschel 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director J Scott Nixon 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director Neil Berkley 757 East South Temple Suite 150 Salt Lake City UT UTAH 84102 Director Biotechnology Decline to Disclose 06c false 2018-03-01 false true true true false 25000 Weild & Co. 132398 None None 777 29TH STREET SUITE 402 BOULDER CO COLORADO 80303 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS KY KENTUCKY LA LOUISIANA MA MASSACHUSETTS MN MINNESOTA MT MONTANA NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO OR OREGON PA PENNSYLVANIA TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WY WYOMING false 3000000 824000 2176000 false 4 300000 true 0 Fee to broker is 10% of cash proceeds, plus a warrant to purchase 10% of conversion shares. 0 true false PROLUNG INC /s/ Mark V. Anderson Mark V. Anderson Chief Financial Officer 2018-03-16